Non-interventional study to evaluate neurotoxicity under adjuvant or palliative therapy with Oxaliplatin Omnicare for patients with colorectal carcinoma

Interventions: Group 1: Patients treated with Oxaliplatin Omnicare are asked to complete a questionnaire every 3 months under therapy and every 6 months after end of treatment. The questionnaire contains questions regarding the effect of treatment on daily life activities and general health condition of the patients. Primary outcome(s): Evaluation of grade and duration of neurotoxicity for patients under therapy with Oxaliplatin Omnicare by means of a patient questionnaire Study Design: Allocation: ; Masking: ; Control: ; Assignment: ; Study design purpose: other